Adamis Pharmaceuticals Gross Profit 2006-2020 | ADMP

Adamis Pharmaceuticals gross profit from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Adamis Pharmaceuticals Annual Gross Profit
(Millions of US $)
2019 $7
2018 $5
2017 $6
2016 $2
2015 $
2014 $
2014 $
2013 $
2012 $
2011 $
2010 $0
2009 $0
2008 $
2007 $
2006 $2
2005 $12
Adamis Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
2020-03-31 $1
2019-12-31 $1
2019-09-30 $2
2019-06-30 $2
2019-03-31 $1
2018-12-31 $1
2018-09-30 $2
2018-06-30 $2
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $2
2017-03-31 $1
2016-12-31 $1
2016-09-30 $0
2016-06-30 $1
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31
2008-12-31 $0
2008-09-30 $0
2008-06-30 $0
2008-03-31
2007-12-31
2007-09-30
2007-06-30
2007-03-31
2006-12-31 $0
2006-09-30 $0
2006-06-30 $1
2006-03-31 $1
2005-12-31 $1
2005-09-30 $2
2005-06-30 $8
2005-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.087B $0.022B
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.039B 40.88
Takeda Pharmaceutical (TAK) Japan $57.380B 10.00
Astellas Pharma (ALPMY) Japan $29.226B 0.00
UCB SA (UCBJF) Belgium $25.188B 0.00
Eisai (ESALY) Japan $24.458B 21.20
Merck (MKGAF) Germany $16.252B 0.00
Catalent (CTLT) United States $13.529B 52.30
Grifols, S.A (GRFS) Spain $12.974B 15.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.177B 51.66
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.019B 42.64
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.688B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.991B 9.59
United Therapeutics (UTHR) United States $4.951B 11.44
Arrowhead Pharmaceuticals (ARWR) United States $4.383B 478.56
Hypermarcas (HYPMY) Brazil $4.336B 15.95
Evotec AG (EVTCY) Germany $4.123B 111.12
Nektar Therapeutics (NKTR) United States $3.944B 0.00
FibroGen (FGEN) United States $3.606B 0.00
ChemoCentryx (CCXI) United States $3.260B 0.00
PTC Therapeutics (PTCT) United States $3.034B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.487B 12.04
Sage Therapeutics (SAGE) United States $2.366B 0.00
Cronos Group (CRON) Canada $2.292B 65.50
Pacira BioSciences (PCRX) United States $2.216B 45.35
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.781B 0.00
Xencor (XNCR) United States $1.715B 0.00
Corcept Therapeutics (CORT) United States $1.713B 16.99
USANA Health Sciences (USNA) United States $1.706B 16.08
Indivior (INVVY) United States $1.618B 20.08
Heron Therapeutics (HRTX) United States $1.477B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.462B 11.18
Akebia Therapeutics (AKBA) United States $1.455B 0.00
Revolution Medicines (RVMD) United States $1.423B 0.00
Zogenix (ZGNX) United States $1.317B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.297B 13.97
Theravance Biopharma (TBPH) Cayman Islands $1.225B 0.00
Karyopharm Therapeutics (KPTI) United States $1.174B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Esperion Therapeutics (ESPR) United States $1.039B 0.00
VAXART, INC (VXRT) United States $1.024B 0.00
Translate Bio (TBIO) United States $0.956B 0.00
Tilray (TLRY) Canada $0.921B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.917B 40.94
Altimmune (ALT) United States $0.851B 0.00
Endo (ENDP) Ireland $0.799B 1.24
BioCryst Pharmaceuticals (BCRX) United States $0.718B 0.00
ImmunoGen (IMGN) United States $0.717B 0.00
Radius Health (RDUS) United States $0.582B 0.00
Trillium Therapeutics (TRIL) Canada $0.565B 0.00
Collegium Pharmaceutical (COLL) United States $0.542B 0.00
Aerie Pharmaceuticals (AERI) United States $0.537B 0.00
Flexion Therapeutics (FLXN) United States $0.523B 0.00
Siga Technologies (SIGA) United States $0.520B 0.00
TherapeuticsMD (TXMD) United States $0.503B 0.00
Ardelyx (ARDX) United States $0.502B 0.00
Molecular Templates (MTEM) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 17.95
Crinetics Pharmaceuticals (CRNX) United States $0.456B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.455B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 10.75
Ocular Therapeutix (OCUL) United States $0.418B 0.00
Organogenesis Holdings (ORGO) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.388B 0.00
DURECT (DRRX) United States $0.384B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.348B 0.00
Calithera Biosciences (CALA) United States $0.331B 0.00
IMV INC (IMV) Canada $0.319B 0.00
PROFOUND MEDICL (PROF) Canada $0.298B 0.00
MEI Pharma (MEIP) United States $0.294B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.293B 0.00
Redhill Biopharma (RDHL) Israel $0.280B 0.00
Harpoon Therapeutics (HARP) United States $0.275B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
Lannett Co Inc (LCI) United States $0.240B 5.27
OptiNose (OPTN) United States $0.234B 0.00
CASI Pharmaceuticals (CASI) United States $0.233B 0.00
Rafael Holdings (RFL) United States $0.221B 0.00
Nivalis Therapeutics (ALPN) United States $0.214B 0.00
Taiwan Liposome (TLC) Taiwan $0.197B 0.00
Onconova Therapeutics (ONTX) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 24.39
Heat Biologics (HTBX) United States $0.184B 0.00
Aquestive Therapeutics (AQST) United States $0.177B 0.00
KalVista Pharmaceuticals (KALV) United States $0.175B 0.00
Jounce Therapeutics (JNCE) United States $0.156B 3.72
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.126B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.116B 0.00
CTI BioPharma (CTIC) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.109B 0.00
Otonomy (OTIC) United States $0.108B 0.00
Xeris Pharmaceuticals (XERS) United States $0.108B 0.00
Biomerica (BMRA) United States $0.107B 0.00
MediWound (MDWD) Israel $0.107B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.099B 0.00
Recro Pharma (REPH) United States $0.096B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.094B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.088B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
Lipocine (LPCN) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Sundial Growers (SNDL) Canada $0.063B 0.00
PolarityTE (PTE) United States $0.061B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Novan (NOVN) United States $0.053B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Addex Therapeutics (ADXN) Switzerland $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.27
Natural Alternatives (NAII) United States $0.046B 0.00
GTx (ONCT) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.81
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.46
Jaguar Animal Health (JAGX) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 31.43
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00